IL150396A0 - Combination chemotherapy - Google Patents

Combination chemotherapy

Info

Publication number: IL150396A0
Authority: IL; Israel
Prior art keywords: combination chemotherapy; combination; chemotherapy; acetyldinaline; docetaxel
Prior art date: 2001-07-02

Application number

IL15039602A

Other languages

English (en)

Original Assignee

Warner Lambert Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-02

Filing date

2002-06-25

Publication date

2002-12-01

2002-06-25 Application filed by Warner Lambert Co filed Critical Warner Lambert Co

2002-12-01 Publication of IL150396A0 publication Critical patent/IL150396A0/xx

Links

238000009096 combination chemotherapy Methods 0.000 title 1
ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 abstract 1
206010028980 Neoplasm Diseases 0.000 abstract 1
201000011510 cancer Diseases 0.000 abstract 1
229960003668 docetaxel Drugs 0.000 abstract 1
230000002195 synergetic effect Effects 0.000 abstract 1
VAZAPHZUAVEOMC-UHFFFAOYSA-N tacedinaline Chemical compound C1=CC(NC(=O)C)=CC=C1C(=O)NC1=CC=CC=C1N VAZAPHZUAVEOMC-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Seasonings (AREA)
Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Insulated Conductors (AREA)
Medicinal Preparation (AREA)

IL15039602A 2001-07-02 2002-06-25 Combination chemotherapy IL150396A0 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US30241501P	2001-07-02	2001-07-02

Publications (1)

Publication Number	Publication Date
IL150396A0 true IL150396A0 (en)	2002-12-01

Family

ID=23167645

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL15039602A IL150396A0 (en)	2001-07-02	2002-06-25	Combination chemotherapy

Country Status (20)

Country	Link
US (1)	US20030083366A1 (de)
EP (1)	EP1273296B1 (de)
JP (1)	JP2003055208A (de)
KR (1)	KR20030015829A (de)
CN (1)	CN1394601A (de)
AT (1)	ATE254915T1 (de)
AU (1)	AU5063302A (de)
CA (1)	CA2391753A1 (de)
CZ (1)	CZ20022216A3 (de)
DE (1)	DE60200101T2 (de)
DK (1)	DK1273296T3 (de)
ES (1)	ES2208626T3 (de)
HK (1)	HK1049794A1 (de)
HU (1)	HUP0202120A3 (de)
IL (1)	IL150396A0 (de)
PL (1)	PL354825A1 (de)
PT (1)	PT1273296E (de)
SK (1)	SK9342002A3 (de)
TR (1)	TR200302193T4 (de)
ZA (1)	ZA200205216B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PE20050206A1 (es) *	2003-05-26	2005-03-26	Schering Ag	Composicion farmaceutica que contiene un inhibidor de histona deacetilasa
US9839667B2 (en)	2005-10-14	2017-12-12	Allergan, Inc.	Prevention and treatment of ocular side effects with a cyclosporin
JP5113038B2 (ja) *	2006-03-23	2013-01-09	テムリック株式会社	癌治療用キットおよび癌治療用医薬組成物
WO2009006555A2 (en) *	2007-07-02	2009-01-08	Yu, Ming	Methods, composition, targets for combinational cancer treatments
WO2012003413A1 (en) *	2010-06-30	2012-01-05	The Broad Institute, Inc.	Novel solid forms of tacedinaline
US8691875B2 (en)	2011-07-01	2014-04-08	Broad Institute, Inc.	Solid forms of tacedinaline

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ219974A (en) *	1986-04-22	1989-08-29	Goedecke Ag	N-(2'-aminophenyl)-benzamide derivatives, process for their preparation and their use in the control of neoplastic diseases
WO1998047500A1 (en) *	1997-04-24	1998-10-29	Warner-Lambert Company	Use of acetyldinaline for the manufacture of a medicament for the treatment of renal cell carcinoma
CA2342981A1 (en) *	1998-09-25	2000-04-06	Warner-Lambert Company	Chemotherapy of cancer with acetyldinaline in combination with gemcitabine, capecitabine or cisplatin
PL348326A1 (en) *	1998-12-22	2002-05-20	Warner Lambert Co	Combination chemotherapy
GB9904386D0 (en) *	1999-02-25	1999-04-21	Pharmacia & Upjohn Spa	Antitumour synergistic composition
WO2001034131A2 (en) *	1999-11-10	2001-05-17	Warner-Lambert Company	Combination chemotherapy

2002
- 2002-06-24 CZ CZ20022216A patent/CZ20022216A3/cs unknown
- 2002-06-25 IL IL15039602A patent/IL150396A0/xx unknown
- 2002-06-26 SK SK934-2002A patent/SK9342002A3/sk not_active Application Discontinuation
- 2002-06-26 AU AU50633/02A patent/AU5063302A/en not_active Abandoned
- 2002-06-26 CA CA002391753A patent/CA2391753A1/en not_active Abandoned
- 2002-06-26 ZA ZA200205216A patent/ZA200205216B/xx unknown
- 2002-06-28 HU HU0202120A patent/HUP0202120A3/hu unknown
- 2002-07-01 DK DK02254337T patent/DK1273296T3/da active
- 2002-07-01 PT PT02254337T patent/PT1273296E/pt unknown
- 2002-07-01 AT AT02254337T patent/ATE254915T1/de not_active IP Right Cessation
- 2002-07-01 ES ES02254337T patent/ES2208626T3/es not_active Expired - Lifetime
- 2002-07-01 DE DE60200101T patent/DE60200101T2/de not_active Expired - Fee Related
- 2002-07-01 TR TR2003/02193T patent/TR200302193T4/xx unknown
- 2002-07-01 EP EP02254337A patent/EP1273296B1/de not_active Expired - Lifetime
- 2002-07-01 PL PL02354825A patent/PL354825A1/xx not_active Application Discontinuation
- 2002-07-01 JP JP2002192378A patent/JP2003055208A/ja active Pending
- 2002-07-02 CN CN02140132A patent/CN1394601A/zh active Pending
- 2002-07-02 KR KR1020020037891A patent/KR20030015829A/ko not_active Ceased
- 2002-07-02 US US10/187,679 patent/US20030083366A1/en not_active Abandoned
2003
- 2003-03-17 HK HK03101938.0A patent/HK1049794A1/zh unknown

Also Published As

Publication number	Publication date
CZ20022216A3 (cs)	2003-05-14
EP1273296A3 (de)	2003-01-22
EP1273296B1 (de)	2003-11-26
KR20030015829A (ko)	2003-02-25
ATE254915T1 (de)	2003-12-15
ZA200205216B (en)	2004-02-10
CN1394601A (zh)	2003-02-05
PL354825A1 (en)	2003-01-13
US20030083366A1 (en)	2003-05-01
CA2391753A1 (en)	2003-01-02
DE60200101D1 (de)	2004-01-08
HU0202120D0 (de)	2002-09-28
HUP0202120A2 (hu)	2003-01-28
PT1273296E (pt)	2004-03-31
AU5063302A (en)	2003-01-09
ES2208626T3 (es)	2004-06-16
EP1273296A2 (de)	2003-01-08
DK1273296T3 (da)	2004-03-01
TR200302193T4 (tr)	2004-02-23
DE60200101T2 (de)	2004-08-26
HK1049794A1 (zh)	2003-05-30
SK9342002A3 (en)	2003-07-01
HUP0202120A3 (en)	2005-01-28
JP2003055208A (ja)	2003-02-26

Similar Documents

Publication	Publication Date	Title
MXPA03007418A (es)	2003-11-18	Tratamiento de cancer.
MXPA05012421A (es)	2006-02-22	Tratamiento sinergistico de cancer usando inmunomeros junto con agentes quimioterapeuticos.
DE60138611D1 (de)	2009-06-18	Synergistische kombinationstherapie zur krebsbehandlung
WO2004034990A3 (en)	2004-07-08	Methods and compositions for use in treating cancer
SG160412A1 (en)	2010-04-29	Anti-igfr1 antibody therapeutic combinations
AU2003293194A8 (en)	2004-06-23	Compositions and methods for treating prostate cancer
WO2004030627A3 (en)	2004-07-01	Synergistic methods and compositions for treating cancer
AU2158601A (en)	2001-05-14	Antiviral agent for use in treatment of cancer
WO2001034131A3 (en)	2002-05-10	Combination chemotherapy
UA83022C2 (uk)	2008-06-10	Аплідин для комбінованої терапії лейкозу та лімфоми
TW200510398A (en)	2005-03-16	Novel compounds
HUP0303261A3 (en)	2012-07-30	Carbamate compounds for use in preventing or treating bipolar disorder
IL150396A0 (en)	2002-12-01	Combination chemotherapy
AU5576601A (en)	2001-11-07	Methods for preventing and treating alopecia induced by chemotherapy or radiotherapy
MXPA03002494A (es)	2004-05-24	Metodo para reducir toxicidad de quimio terapias combinadas.
IL164356A (en)	2010-11-30	Use of alpha- bromo or alpha-chloro acryloyl distamycin derivatives in the preparation of medicaments for treating cancer
GB0223325D0 (en)	2002-11-13	Treating cancer
MXPA05002477A (es)	2005-10-19	Asialo-interferones y el tratamiento de cancer de higado.
AU2002360454A8 (en)	2003-06-10	Methods and compositions for treating cancer
ECSP003755A (es)	2001-03-22	Quimioterapia de combinacion
UA34368A (uk)	2001-02-15	Спосіб лікування рака молочної залози
ZA200307471B (en)	2005-01-03	Carbamate compounds for use in preventing or treating bipolar disorder.
CA96877S (en)	2003-05-15	Game board
GB0216634D0 (en)	2002-08-28	Treating cancer
HK1050630A (en)	2003-07-04	Synergistic methods and compositions for treating cancer